For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241105:nRSE0549La&default-theme=true
RNS Number : 0549L Polar Capital Global Health Tst PLC 05 November 2024
5(th) November 2024
Polar Capital Global Healthcare Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 31(st)
October 2024 full Portfolio listing as at 30(th) September 2024 available from
company's website.
Polar Capital Global Healthcare Trust plc is pleased to announce that as at
31(st) October 2024 the top ten equity holdings and the sector and geographic
breakdown were as follows:
Top 10 Holdings %
Eli Lilly & Co 8.3%
UnitedHealth Group 7.6%
Novo Nordisk A/S 6.0%
AbbVie 5.0%
Roche 4.5%
Sandoz Group AG 3.5%
Sanofi 3.3%
Terumo Corp 3.3%
Fresenius SE & Co KGaA 3.2%
Intuitive Surgical 3.2%
Total 47.9%
Sector Exposure %
Pharmaceuticals 31.6%
Biotechnology 20.8%
Healthcare Equipment 15.5%
Life Sciences Tools & Services 8.2%
Managed Healthcare 7.6%
Healthcare Supplies 5.2%
Healthcare Services 3.2%
Healthcare Facilities 2.9%
Healthcare Technology 2.3%
Metal, Glass & Plastic Containers 1.9%
Healthcare Distributors 0.8%
Cash 0.1%
Total 100.0%
Geographic Exposure %
United States 46.1%
Switzerland 12.9%
Denmark 11.4%
Japan 6.2%
France 5.7%
Germany 3.2%
Belgium 3.1%
Sweden 3.1%
Netherlands 3.1%
United Kingdom 2.4%
Italy 1.9%
Ireland 0.8%
Cash 0.1%
Total 100.0%
The monthly factsheet will usually be available on the Company's website on
the 10(th) working day after the month end and includes a commentary by the
investment manager. www.Polarcapitalhealthcaretrust.co
(http://www.Polarcapitalhealthcaretrust.com) m
(http://www.Polarcapitalhealthcaretrust.com)
Neither the contents of the Company's website nor the contents of any website
accessible from the hyperlinks on the Company's website (or any other website)
is incorporated into or forms part of this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PFUDZMGMVKMGDZM
Recent news on Polar Capital Global Healthcare Trust